EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Would you like to take some more ruxolitinib after your fedratinib?

Jean-Christophe Ianotto iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Jean-Christophe Ianotto. Beteiligte Einrichtung: Department of Haematology, Institute of Oncology and Haematology, University Hospital of Brest, Brest, France. Hauptthemen laut MEDLINE: Nitriles, Pyrazoles, Pyrimidines, Primary Myelofibrosis. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Europe, ruxolitinib and fedratinib are the only JAK2 inhibitors available in local pharmacies. According to trial data, myelofibrosis patients should mostly receive ruxolitinib as first‐line treatment and fedratinib in case of failure or intolerance (depending on their profile). Is it possible to reverse the choice of these drugs? Commentary on: Palandri et al. Ruxolitinib after Fedratinib failure in patients with myelofibrosis: a real‐world case series. Br J Haematol 2024; 205:1605‐1609.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NitrilesPyrazolesPyrimidinesPrimary MyelofibrosisHumansPyrrolidinesSulfonamidesJanus Kinase 2Protein Kinase InhibitorsBenzenesulfonamides

Stichwörter der Autor:innen

fedratinibmyelofibrosisruxolitinib

Substanzen

ruxolitinibNitrilesPyrazolesPyrimidinesfedratinibPyrrolidinesSulfonamidesJanus Kinase 2JAK2 protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Haematology, Institute of Oncology and Haematology, University Hospital of Brest, Brest, France.

ORCID-Profile: Jean-Christophe Ianotto

Zitieren

APA

Ianotto, J. C. (2024). Would you like to take some more ruxolitinib after your fedratinib?. British Journal of Haematology. https://doi.org/10.1111/bjh.19695

Vancouver

Ianotto JC. Would you like to take some more ruxolitinib after your fedratinib?. British Journal of Haematology. 2024. doi:10.1111/bjh.19695

BibTeX
@article{Ianotto2024,
  author = {Ianotto, Jean-Christophe},
  title = {Would you like to take some more ruxolitinib after your fedratinib?},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19695}
}
Kostenlos starten →